Company: Intec Pharma LTD
Quote:NASDAQ: NTEC
Buy Target : $6.90 (original hold) $7.25 Second entry
Sell Target: $30 EOY ,
Description: Intec Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. It's Accordion Pill is an oral drug delivery system that is...
